Bkemv Injection, Solution, Concentrate
Product Images NDC 55513-180

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bkemv (NDC 55513-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
BKEMV 300 mg/30 mL (eculizumab-aeeb) injection, solution concentrate for intravenous infusion. The label indicates a single-dose vial requiring dilution prior to use, with no preservatives. Manufactured by Amgen Inc. NDC 55513-180-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.